A wife whose husband will not be eligible for new Alzheimer’s drugs has implored health leaders to ensure that others like ...
The most effective drug for Alzheimer’s has been blocked for use on the NHS. Regulators have declared the new treatment for ...
New disease-modifying Alzheimer’s drugs work best when they are given to patients in the early stages of disease. The drug ...
The UK's drug regulator granted approval for Kisunla, an Alzheimer's medication, while an independent assessment body rejected its NHS funding on grounds of cost. The approval marks the second ...
The U.K. watchdog declines to endorse Eli Lilly's Alzheimer's drug donanemab, citing lack of value for the NHS and ...
UK's Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly's treatment for early Alzheimer's, the ...
Donanemab is a targeted antibody drug which slows down the early stages of Alzheimer’s. The drug, and another new drug for Alzheimer’s called lecanemab, have been billed as a huge step forward in ...
The 78-year-old has taken part in two 18-month trials for donanemab. Donanemab is given to patients via an intravenous drip once every four weeks. Mr Almond received his treatment ...
Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the ...
The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...
VALPARAISO — A 62-year-old Porter woman faces a felony neglect charge after allegedly leaving a man with advanced Alzhiemer's disease lying unconscious on the floor of his home, records show ...
Researchers do not believe Alzheimer’s disease has one specific cause. Instead, a combination of genetic, environmental, and lifestyle risk factors can contribute to the condition. Alzheimer’s ...